Aeterna Zentaris Names Dr. Richard Sachse as Chief Scientific Officer
January 03, 2014 at 07:39 AM EST
Aeterna Zentaris. (NASDAQ: AEZS ) today announced the appointment of Richard Sachse, MD, PhD, as Senior Vice President, Chief Scientific Officer. Before joining Aeterna Zentaris, Dr. Sachse was Vice President, Head of Global Translational Medicine at Boehringer Ingelheim. See full press release (c) 2014 Benzinga.com. Benzinga